Skip to main content
Top
Published in: Clinical and Experimental Nephrology 3/2018

01-06-2018 | Original article

Effect of Npt2b deletion on intestinal and renal inorganic phosphate (Pi) handling

Authors: Kayo Ikuta, Hiroko Segawa, Shohei Sasaki, Ai Hanazaki, Toru Fujii, Aoi Kushi, Yuka Kawabata, Ruri Kirino, Sumire Sasaki, Miwa Noguchi, Ichiro Kaneko, Sawako Tatsumi, Otoya Ueda, Naoko A. Wada, Hiromi Tateishi, Mami Kakefuda, Yosuke Kawase, Shuichi Ohtomo, Yasuhiro Ichida, Akira Maeda, Kou-ichi Jishage, Naoshi Horiba, Ken-ichi Miyamoto

Published in: Clinical and Experimental Nephrology | Issue 3/2018

Login to get access

Abstract

Background

Hyperphosphatemia is common in chronic kidney disease and is associated with morbidity and mortality. The intestinal Na+-dependent phosphate transporter Npt2b is thought to be an important molecular target for the prevention of hyperphosphatemia. The role of Npt2b in the net absorption of inorganic phosphate (Pi), however, is controversial.

Methods

In the present study, we made tamoxifen-inducible Npt2b conditional knockout (CKO) mice to analyze systemic Pi metabolism, including intestinal Pi absorption.

Results

Although the Na+-dependent Pi transport in brush-border membrane vesicle uptake levels was significantly decreased in the distal intestine of Npt2b CKO mice compared with control mice, plasma Pi and fecal Pi excretion levels were not significantly different. Data obtained using the intestinal loop technique showed that Pi uptake in Npt2b CKO mice was not affected at a Pi concentration of 4 mM, which is considered the typical luminal Pi concentration after meals in mice. Claudin, which may be involved in paracellular pathways, as well as claudin-2, 12, and 15 protein levels were significantly decreased in the Npt2b CKO mice. Thus, Npt2b deficiency did not affect Pi absorption within the range of Pi concentrations that normally occurs after meals.

Conclusion

These findings indicate that abnormal Pi metabolism may also be involved in tight junction molecules such as Cldns that are affected by Npt2b deficiency.
Appendix
Available only for authorised users
Literature
1.
go back to reference Block GA, Kilpatrick RD, Lowe KA, Wang W, Danese MD. Ckd-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis. Clin J Am Soc Nephrol. 2013;8:2132–40.CrossRefPubMedPubMedCentral Block GA, Kilpatrick RD, Lowe KA, Wang W, Danese MD. Ckd-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis. Clin J Am Soc Nephrol. 2013;8:2132–40.CrossRefPubMedPubMedCentral
2.
go back to reference Cannata-Andia JB, Martin KJ. The challenge of controlling phosphorus in chronic kidney disease. Nephrol Dial Transplant. 2016;31:541–7.CrossRefPubMed Cannata-Andia JB, Martin KJ. The challenge of controlling phosphorus in chronic kidney disease. Nephrol Dial Transplant. 2016;31:541–7.CrossRefPubMed
3.
go back to reference Vervloet MG, Sezer S, Massy ZA, Johansson L, Cozzolino M, Fouque D, Disease-Mineral E-EWGoCK, Bone D, the European Renal Nutrition Working G. The role of phosphate in kidney disease. Nat Rev Nephrol. 2017;13:27–38.CrossRefPubMed Vervloet MG, Sezer S, Massy ZA, Johansson L, Cozzolino M, Fouque D, Disease-Mineral E-EWGoCK, Bone D, the European Renal Nutrition Working G. The role of phosphate in kidney disease. Nat Rev Nephrol. 2017;13:27–38.CrossRefPubMed
4.
go back to reference Wagner CA, Hernando N, Forster IC, Biber J. The slc34 family of sodium-dependent phosphate transporters. Pflugers Archiv. 2014;466:139–53.CrossRefPubMed Wagner CA, Hernando N, Forster IC, Biber J. The slc34 family of sodium-dependent phosphate transporters. Pflugers Archiv. 2014;466:139–53.CrossRefPubMed
5.
go back to reference Ohi A, Hanabusa E, Ueda O, Segawa H, Horiba N, Kaneko I, Kuwahara S, Mukai T, Sasaki S, Tominaga R, Furutani J, Aranami F, Ohtomo S, Oikawa Y, Kawase Y, Wada NA, Tachibe T, Kakefuda M, Tateishi H, Matsumoto K, Tatsumi S, Kido S, Fukushima N, Jishage K, Miyamoto K. Inorganic phosphate homeostasis in sodium-dependent phosphate cotransporter npt2b(+)/(−) mice. Am J Physiol Renal Physiol. 2011;301:F1105–13.CrossRefPubMed Ohi A, Hanabusa E, Ueda O, Segawa H, Horiba N, Kaneko I, Kuwahara S, Mukai T, Sasaki S, Tominaga R, Furutani J, Aranami F, Ohtomo S, Oikawa Y, Kawase Y, Wada NA, Tachibe T, Kakefuda M, Tateishi H, Matsumoto K, Tatsumi S, Kido S, Fukushima N, Jishage K, Miyamoto K. Inorganic phosphate homeostasis in sodium-dependent phosphate cotransporter npt2b(+)/(−) mice. Am J Physiol Renal Physiol. 2011;301:F1105–13.CrossRefPubMed
7.
go back to reference Sabbagh Y, O’Brien SP, Song W, Boulanger JH, Stockmann A, Arbeeny C, Schiavi SC. Intestinal npt2b plays a major role in phosphate absorption and homeostasis. J Am Soc Nephrol. 2009;20:2348–58.CrossRefPubMedPubMedCentral Sabbagh Y, O’Brien SP, Song W, Boulanger JH, Stockmann A, Arbeeny C, Schiavi SC. Intestinal npt2b plays a major role in phosphate absorption and homeostasis. J Am Soc Nephrol. 2009;20:2348–58.CrossRefPubMedPubMedCentral
8.
go back to reference Labonte ED, Carreras CW, Leadbetter MR, Kozuka K, Kohler J, Koo-McCoy S, He L, Dy E, Black D, Zhong Z, Langsetmo I, Spencer AG, Bell N, Deshpande D, Navre M, Lewis JG, Jacobs JW, Charmot D. Gastrointestinal inhibition of sodium-hydrogen exchanger 3 reduces phosphorus absorption and protects against vascular calcification in ckd. J Am Soc Nephrol. 2015;26:1138–49.CrossRefPubMed Labonte ED, Carreras CW, Leadbetter MR, Kozuka K, Kohler J, Koo-McCoy S, He L, Dy E, Black D, Zhong Z, Langsetmo I, Spencer AG, Bell N, Deshpande D, Navre M, Lewis JG, Jacobs JW, Charmot D. Gastrointestinal inhibition of sodium-hydrogen exchanger 3 reduces phosphorus absorption and protects against vascular calcification in ckd. J Am Soc Nephrol. 2015;26:1138–49.CrossRefPubMed
9.
go back to reference Pan W, Borovac J, Spicer Z, Hoenderop JG, Bindels RJ, Shull GE, Doschak MR, Cordat E, Alexander RT. The epithelial sodium/proton exchanger, nhe3, is necessary for renal and intestinal calcium (re)absorption. Am J Physiol Renal Physiol. 2012;302:F943–56.CrossRefPubMed Pan W, Borovac J, Spicer Z, Hoenderop JG, Bindels RJ, Shull GE, Doschak MR, Cordat E, Alexander RT. The epithelial sodium/proton exchanger, nhe3, is necessary for renal and intestinal calcium (re)absorption. Am J Physiol Renal Physiol. 2012;302:F943–56.CrossRefPubMed
10.
go back to reference Osoegawa K, Tateno M, Woon PY, Frengen E, Mammoser AG, Catanese JJ, Hayashizaki Y, de Jong PJ. Bacterial artificial chromosome libraries for mouse sequencing and functional analysis. Genome Res. 2000;10:116–28.PubMedPubMedCentral Osoegawa K, Tateno M, Woon PY, Frengen E, Mammoser AG, Catanese JJ, Hayashizaki Y, de Jong PJ. Bacterial artificial chromosome libraries for mouse sequencing and functional analysis. Genome Res. 2000;10:116–28.PubMedPubMedCentral
11.
go back to reference Zhang Y, Buchholz F, Muyrers JP, Stewart AF. A new logic for DNA engineering using recombination in Escherichia coli. Nat Genet. 1998;20:123–8.CrossRefPubMed Zhang Y, Buchholz F, Muyrers JP, Stewart AF. A new logic for DNA engineering using recombination in Escherichia coli. Nat Genet. 1998;20:123–8.CrossRefPubMed
12.
go back to reference Zhang Y, Muyrers JP, Testa G, Stewart AF. DNA cloning by homologous recombination in Escherichia coli. Nat Biotechnol. 2000;18:1314–7.CrossRefPubMed Zhang Y, Muyrers JP, Testa G, Stewart AF. DNA cloning by homologous recombination in Escherichia coli. Nat Biotechnol. 2000;18:1314–7.CrossRefPubMed
13.
go back to reference Tominaga T, Abe H, Ueda O, Goto C, Nakahara K, Murakami T, Matsubara T, Mima A, Nagai K, Araoka T, Kishi S, Fukushima N, Jishage K, Doi T. Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathy. J Biol Chem. 2011;286:20109–16.CrossRefPubMedPubMedCentral Tominaga T, Abe H, Ueda O, Goto C, Nakahara K, Murakami T, Matsubara T, Mima A, Nagai K, Araoka T, Kishi S, Fukushima N, Jishage K, Doi T. Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathy. J Biol Chem. 2011;286:20109–16.CrossRefPubMedPubMedCentral
14.
go back to reference Silva IV, Cebotaru V, Wang H, Wang XT, Wang SS, Guo G, Devuyst O, Thakker RV, Guggino WB, Guggino SE. The clc-5 knockout mouse model of dent’s disease has renal hypercalciuria and increased bone turnover. J Bone Miner Res. 2003;18:615–23.CrossRefPubMed Silva IV, Cebotaru V, Wang H, Wang XT, Wang SS, Guo G, Devuyst O, Thakker RV, Guggino WB, Guggino SE. The clc-5 knockout mouse model of dent’s disease has renal hypercalciuria and increased bone turnover. J Bone Miner Res. 2003;18:615–23.CrossRefPubMed
15.
go back to reference Segawa H, Onitsuka A, Kuwahata M, Hanabusa E, Furutani J, Kaneko I, Tomoe Y, Aranami F, Matsumoto N, Ito M, Matsumoto M, Li M, Amizuka N, Miyamoto K. Type iic sodium-dependent phosphate transporter regulates calcium metabolism. J Am Soc Nephrol. 2009;20:104–13.CrossRefPubMedPubMedCentral Segawa H, Onitsuka A, Kuwahata M, Hanabusa E, Furutani J, Kaneko I, Tomoe Y, Aranami F, Matsumoto N, Ito M, Matsumoto M, Li M, Amizuka N, Miyamoto K. Type iic sodium-dependent phosphate transporter regulates calcium metabolism. J Am Soc Nephrol. 2009;20:104–13.CrossRefPubMedPubMedCentral
16.
go back to reference Yoon JY, Woo SI, Kim H, Sun YH, Hahn YS. Fractional exhaled nitric oxide and forced expiratory flow between 25% and 75% of vital capacity in children with controlled asthma. Korean J Pediatrics. 2012;55:330–6.CrossRef Yoon JY, Woo SI, Kim H, Sun YH, Hahn YS. Fractional exhaled nitric oxide and forced expiratory flow between 25% and 75% of vital capacity in children with controlled asthma. Korean J Pediatrics. 2012;55:330–6.CrossRef
17.
go back to reference Marks J, Lee GJ, Nadaraja SP, Debnam ES, Unwin RJ. Experimental and regional variations in Na+-dependent and Na+-independent phosphate transport along the rat small intestine and colon. Physiol Reports. 2015;3. Marks J, Lee GJ, Nadaraja SP, Debnam ES, Unwin RJ. Experimental and regional variations in Na+-dependent and Na+-independent phosphate transport along the rat small intestine and colon. Physiol Reports. 2015;3.
18.
go back to reference Masaoka Y, Tanaka Y, Kataoka M, Sakuma S, Yamashita S. Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract. Eur J Pharm Sci. 2006;29:240–50.CrossRefPubMed Masaoka Y, Tanaka Y, Kataoka M, Sakuma S, Yamashita S. Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract. Eur J Pharm Sci. 2006;29:240–50.CrossRefPubMed
19.
go back to reference Tanaka Y, Goto T, Kataoka M, Sakuma S, Yamashita S. Impact of luminal fluid volume on the drug absorption after oral administration: analysis based on in vivo drug concentration-time profile in the gastrointestinal tract. J Pharm Sci. 2015;104:3120–7.CrossRefPubMed Tanaka Y, Goto T, Kataoka M, Sakuma S, Yamashita S. Impact of luminal fluid volume on the drug absorption after oral administration: analysis based on in vivo drug concentration-time profile in the gastrointestinal tract. J Pharm Sci. 2015;104:3120–7.CrossRefPubMed
20.
go back to reference Furutani J, Segawa H, Aranami F, Kuwahara S, Sugano M, Bannai K, Yamato H, Ito M, Miyamoto K. Dietary inorganic phosphorus regulates the intestinal peptide transporter pept1. J Renal Nutr. 2013;23:e11–20.CrossRef Furutani J, Segawa H, Aranami F, Kuwahara S, Sugano M, Bannai K, Yamato H, Ito M, Miyamoto K. Dietary inorganic phosphorus regulates the intestinal peptide transporter pept1. J Renal Nutr. 2013;23:e11–20.CrossRef
21.
go back to reference Thorens B, Sarkar HK, Kaback HR, Lodish HF. Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells. Cell. 1988;55:281–90.CrossRefPubMed Thorens B, Sarkar HK, Kaback HR, Lodish HF. Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells. Cell. 1988;55:281–90.CrossRefPubMed
22.
go back to reference Hilfiker H, Hattenhauer O, Traebert M, Forster I, Murer H, Biber J. Characterization of a murine type ii sodium-phosphate cotransporter expressed in mammalian small intestine. Proc Natl Acad Sci USA. 1998;95:14564–9.CrossRefPubMedPubMedCentral Hilfiker H, Hattenhauer O, Traebert M, Forster I, Murer H, Biber J. Characterization of a murine type ii sodium-phosphate cotransporter expressed in mammalian small intestine. Proc Natl Acad Sci USA. 1998;95:14564–9.CrossRefPubMedPubMedCentral
23.
go back to reference Marks J, Debnam ES, Unwin RJ. The role of the gastrointestinal tract in phosphate homeostasis in health and chronic kidney disease. Curr Opin Nephrol Hypertens. 2013;22:481–7.CrossRefPubMedPubMedCentral Marks J, Debnam ES, Unwin RJ. The role of the gastrointestinal tract in phosphate homeostasis in health and chronic kidney disease. Curr Opin Nephrol Hypertens. 2013;22:481–7.CrossRefPubMedPubMedCentral
24.
go back to reference Segawa H, Shiozaki Y, Kaneko I, Miyamoto K. The role of sodium-dependent phosphate transporter in phosphate homeostasis. J Nutr Sci Vitaminol. 2015;61(Suppl):S119–21.CrossRefPubMed Segawa H, Shiozaki Y, Kaneko I, Miyamoto K. The role of sodium-dependent phosphate transporter in phosphate homeostasis. J Nutr Sci Vitaminol. 2015;61(Suppl):S119–21.CrossRefPubMed
25.
go back to reference Andrade L, Reboucas NA, Seguro AC. Down-regulation of na + transporters and aqp2 is responsible for acyclovir-induced polyuria and hypophosphatemia. Kidney Int. 2004;65:175–83.CrossRefPubMed Andrade L, Reboucas NA, Seguro AC. Down-regulation of na + transporters and aqp2 is responsible for acyclovir-induced polyuria and hypophosphatemia. Kidney Int. 2004;65:175–83.CrossRefPubMed
26.
go back to reference Procino G, Carmosino M, Tamma G, Gouraud S, Laera A, Riccardi D, Svelto M, Valenti G. Extracellular calcium antagonizes forskolin-induced aquaporin 2 trafficking in collecting duct cells. Kidney Int. 2004;66:2245–55.CrossRefPubMed Procino G, Carmosino M, Tamma G, Gouraud S, Laera A, Riccardi D, Svelto M, Valenti G. Extracellular calcium antagonizes forskolin-induced aquaporin 2 trafficking in collecting duct cells. Kidney Int. 2004;66:2245–55.CrossRefPubMed
27.
go back to reference Forster IC, Virkki L, Bossi E, Murer H, Biber J. Electrogenic kinetics of a mammalian intestinal type iib na(+)/p(i) cotransporter. J Membr Biol. 2006;212:177–90.CrossRefPubMed Forster IC, Virkki L, Bossi E, Murer H, Biber J. Electrogenic kinetics of a mammalian intestinal type iib na(+)/p(i) cotransporter. J Membr Biol. 2006;212:177–90.CrossRefPubMed
28.
go back to reference Mc HG, Parsons DS. The absorption of inorganic phosphate from the small intestine of the rat. Q J Exp Physiol Cognate Med Sci. 1956;41:398–412.CrossRef Mc HG, Parsons DS. The absorption of inorganic phosphate from the small intestine of the rat. Q J Exp Physiol Cognate Med Sci. 1956;41:398–412.CrossRef
29.
go back to reference Breves G, Schroder B. Comparative aspects of gastrointestinal phosphorus metabolism. Nutr Res Rev. 1991;4:125–40.CrossRefPubMed Breves G, Schroder B. Comparative aspects of gastrointestinal phosphorus metabolism. Nutr Res Rev. 1991;4:125–40.CrossRefPubMed
30.
go back to reference Barmeyer C, Schulzke JD, Fromm M. Claudin-related intestinal diseases. Semin Cell Dev Biol. 2015;42:30–8.CrossRefPubMed Barmeyer C, Schulzke JD, Fromm M. Claudin-related intestinal diseases. Semin Cell Dev Biol. 2015;42:30–8.CrossRefPubMed
31.
go back to reference Krug SM, Schulzke JD, Fromm M. Tight junction, selective permeability, and related diseases. Semin Cell Dev Biol. 2014;36:166–76.CrossRefPubMed Krug SM, Schulzke JD, Fromm M. Tight junction, selective permeability, and related diseases. Semin Cell Dev Biol. 2014;36:166–76.CrossRefPubMed
32.
34.
go back to reference Amasheh S, Milatz S, Krug SM, Bergs M, Amasheh M, Schulzke JD, Fromm M. Na+ absorption defends from paracellular back-leakage by claudin-8 upregulation. Biochem Biophys Res Commun. 2009;378:45–50.CrossRefPubMed Amasheh S, Milatz S, Krug SM, Bergs M, Amasheh M, Schulzke JD, Fromm M. Na+ absorption defends from paracellular back-leakage by claudin-8 upregulation. Biochem Biophys Res Commun. 2009;378:45–50.CrossRefPubMed
35.
go back to reference Fujita H, Sugimoto K, Inatomi S, Maeda T, Osanai M, Uchiyama Y, Yamamoto Y, Wada T, Kojima T, Yokozaki H, Yamashita T, Kato S, Sawada N, Chiba H. Tight junction proteins claudin-2 and -12 are critical for vitamin d-dependent Ca2+ absorption between enterocytes. Mol Biol Cell. 2008;19:1912–21.CrossRefPubMedPubMedCentral Fujita H, Sugimoto K, Inatomi S, Maeda T, Osanai M, Uchiyama Y, Yamamoto Y, Wada T, Kojima T, Yokozaki H, Yamashita T, Kato S, Sawada N, Chiba H. Tight junction proteins claudin-2 and -12 are critical for vitamin d-dependent Ca2+ absorption between enterocytes. Mol Biol Cell. 2008;19:1912–21.CrossRefPubMedPubMedCentral
36.
go back to reference Wada M, Tamura A, Takahashi N, Tsukita S. Loss of claudins 2 and 15 from mice causes defects in paracellular Na+ flow and nutrient transport in gut and leads to death from malnutrition. Gastroenterology. 2013;144:369–80.CrossRefPubMed Wada M, Tamura A, Takahashi N, Tsukita S. Loss of claudins 2 and 15 from mice causes defects in paracellular Na+ flow and nutrient transport in gut and leads to death from malnutrition. Gastroenterology. 2013;144:369–80.CrossRefPubMed
Metadata
Title
Effect of Npt2b deletion on intestinal and renal inorganic phosphate (Pi) handling
Authors
Kayo Ikuta
Hiroko Segawa
Shohei Sasaki
Ai Hanazaki
Toru Fujii
Aoi Kushi
Yuka Kawabata
Ruri Kirino
Sumire Sasaki
Miwa Noguchi
Ichiro Kaneko
Sawako Tatsumi
Otoya Ueda
Naoko A. Wada
Hiromi Tateishi
Mami Kakefuda
Yosuke Kawase
Shuichi Ohtomo
Yasuhiro Ichida
Akira Maeda
Kou-ichi Jishage
Naoshi Horiba
Ken-ichi Miyamoto
Publication date
01-06-2018
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 3/2018
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-017-1497-3

Other articles of this Issue 3/2018

Clinical and Experimental Nephrology 3/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.